Claim Pending
an abstract featuring new clinical data on vapendavir -- the company's...
Altesa BioSciences: an abstract featuring new clinical data on vapendavir -- the company's investigational or... Published Jul 7, 2026. Status: Pending. The cl...
an abstract featuring new clinical data on vapendavir -- the company's investigational oral rhinovirus capsid inhibitor -- has been accepted for an oral presentation at the European Respiratory Society (ERS) International Congress 2026 taking place September 5–9, 2026, in Barcelona, Spain.
FactTracker assessment
The claim states that an abstract featuring new clinical data on vapendavir has been accepted for an oral pre...
Verification rule: Event occurs: Altesa BioSciences presents an oral presentation featuring vapendavir data at the European Respiratory Society International Congress 2026.; window 2026-07-07 to open
Verification criteria: Altesa BioSciences presents an oral presentation featuring vapendavir data at the European Respiratory Society International Congress 2026.
Original source: biospace.com